Pharmaceutical Glass Packaging Market
Pharmaceutical Glass Packaging Market Study by Plastic & Polymer, Paper & Paperboard, Glass, and Aluminum Foil for Bottles, Syringes, Ampoules & Vials, and Cartridges from 2024 to 2034
Analysis of Pharmaceutical Glass Packaging Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Pharmaceutical Glass Packaging Market Outlook (2024 to 2034)
A detailed analysis by skilled analysts at Fact.MR reveals that the global pharmaceutical glass packaging market size is estimated at US$ 18.4 billion in 2024 and is forecast to expand at a CAGR of 9% to end up at a value of US$ 43.6 billion by the end of 2034.
Packaging plays an important part in the pharmaceutical sector since it ensures safety and security while keeping and shipping various types of pharmaceuticals and treatment products. Glass is recommended for packaging pharmaceutical items over other packaging materials because of its inert nature, which reduces the danger of chemical reactions between the container and the product. Furthermore, glass is clear in structure, allowing for easy observation of the content inside the package, and it is impermeable to gas and moisture, assuring the stability of pharmaceutical items.
One of the current pharmaceutical glass packaging market trends is the increasing focus on sustainability and environmentally friendly packaging solutions. Glass is considered a highly sustainable packaging material that can be 100 percent recyclable, and during the recycling process, it does not lose its quality or purity, This makes glass an attractive choice for companies which operate within the pharmaceutical industry and want to meet consumer demand for eco-friendly products.
Key Market Growth Drivers
- Specialty glass packaging options, such as amber glass vials and syringes, are becoming increasingly popular because they provide superior light and UV radiation protection. These glass materials are very crucial for light-sensitive medications, as they maintain their stability and efficacy throughout their shelf life.
- Pharmaceutical glass packaging emphasizes the necessity of product safety and integrity in the pharmaceutical business.
- Glass containers provide exceptional barrier qualities that protect pharmaceutical items from external pollutants, moisture, and deterioration.
- Intrinsic stillness of glass guarantees that medications stay stable and effective throughout their shelf life, which contributes to patient safety and compliance with regulations.
- Maintaining product quality is important in the pharmaceutical sector, as this is directly related to brand reputation.
- Glass packaging provides benefits such as a clear view of the contents, simplicity of opening, and compatibility with a wide range of dosage forms, including liquids, solids, and injectables.
| Report Attributes | Details |
|---|---|
| Pharmaceutical Glass Packaging Market Size (2024E) | US$ 18.4 Billion |
| Forecasted Market Value (2034F) | US$ 43.6 Billion |
| Global Market Growth Rate (2024 to 2034) | 9% CAGR |
| North America Market Value (2034F) | US$ 15.2 Billion |
| East Asia Market Value (2024E) | US$ 22.1 Billion |
| Bottle packaging (2034F) | US$ 18.3 Billion |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors are Influencing Sales of Pharmaceutical Glass Packaging Solutions?
“Focus on Preservation of Product Efficacy and Patient Well-being”
Manufacturers in the pharmaceutical sector need to prioritize packaging solutions that guarantee the preservation of product efficacy and customer well-being. Glass packaging is a crucial solution for these challenges, due to its inherent properties that provide a protective barrier against external factors, prevent contamination and maintain the integrity of pharmaceutical formulations. The transparency of glass allows for easy verification of authenticity, boosting confidence through visual inspection.
Significance of glass in upholding product safety and integrity across the supply chain is further underscored by its chemical inertness and compliance with stringent regulatory standards. Consequently, the increasing demand for pharmaceutical glass packaging is being driven by the necessity to uphold good standards of quality and reliability in medication delivery.
“Coating Technology Innovations Enhancing Protective Properties of Glass Packaging”
Innovation in glass manufacturing methods, coating technologies, and packaging design enhancements is boosting demand for pharmaceutical glass packaging solutions. Advancements in technology, such as borosilicate glass formulations and anti-counterfeiting features, enable manufacturers to meet changing market needs and enhance product uniqueness, sustainability, and user satisfaction.
What are the Challenges Faced by Pharmaceutical Glass Packaging Providers?
“Fragility of Glass Leading to Risk of Breakage During Transportation”
Fragility of glass poses a significant challenge. Even though glass is known for its protection, it is prone to breakage during handling, shipping, and storage in pharmaceutical supply warehouses. Particularly, there is a high chance of glass breaking due to shocks, vibrations, and sudden impacts during transportation, which not only affects the contents but also creates safety risks for personnel involved in handling the damage.
To prevent glass containers from breaking by accident, care must be taken during the filling, packing, and sealing stages. The integrity of the container is compromised by even minor negligence, leaving the pharmaceutical product vulnerable to infection or spoilage.
“Stiff Competition from Alternative Packaging Solutions”
Glass is the preferred choice in pharmaceutical product packaging especially for liquid medicines, due to its ability to preserve product integrity and durability. However, there are multiple alternatives available on the market such as plastic and polymers which is becoming a hurdle to the growth of the pharmaceutical glass packaging market. Plastic has many advantages over glass, such as low manufacturing costs and lightweight nature. Plastic can be molded into various shapes and sizes.
Polymers such as polyethylene terephthalate (PET) and polypropylene (PP) packaging are increasing in popularity in the pharmaceutical sector due to their superior barrier properties for many types of drug formulations. They provide good protection against light, moisture, and oxygen.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
East Asia accounts for 22.1% of the global pharmaceutical glass packaging market share due to increasing healthcare expenditure in the region. China is an important center for pharmaceuticals in the region, with a strong production base and expanding domestic demand.
Why is China an Important Market for Pharmaceutical Glass Packaging Manufacturers?
“Increased Demand for Pharmaceuticals Due to Rising Prevalence of Chronic Diseases”
| Attribute | China |
|---|---|
| Market Value (2024E) | US$ 18 Billion |
| Growth Rate (2024–2034) | 9.5% CAGR |
| Projected Value (2034F) | US$ 4.5 Billion |
China is known as one of the world's major pharmaceutical marketplaces because of its vast population, growing middle class, and rising expenditure on healthcare. The country's aging population and increased prevalence of chronic illnesses are boosting demand for pharmaceutical products. Also, China is investing heavily in its healthcare infrastructure, which includes hospitals and pharmaceutical manufacturing units. These factors are creating new opportunities for manufacturers of pharmaceutical glass to provide packaging materials to meet the growing demand.
What Variables are Driving Sales of Pharmaceutical Glass Packaging Solutions in the United States?
“Growing Consumer Awareness of Sustainability and Eco-friendly Packaging”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.5 Billion |
| Growth Rate (2024 to 2034) | 9.4% CAGR |
| Projected Value (2034F) | US$ 3.8 Billion |
The United States is one of the most important market players and accounts for 50% of the North American market share. Growing awareness among consumers about sustainability and eco-friendly packaging is driving demand for glass packaging for pharmaceutical products, as glass is considered more environmentally friendly compared to plastic alternative options due to its recyclable nature.
Category-wise Insights
As per Fact.MR, bottles are projected to occupy a leading market share by 2034. Demand for syringes is forecast to increase at a 9% CAGR through 2034.
Why is Demand for Bottle Packaging Increasing in the Pharmaceutical Industry?
“Functional Design of Bottles for Storage and Packaging and Their Eco-friendliness”
| Attribute | Bottles |
|---|---|
| Market Value (2024E) | US$ 8 Billion |
| Growth Rate (2024–2034) | 8.6% CAGR |
| Projected Value (2034F) | US$ 18.3 Billion |
Even though sales of ampoules and vials are projected to expand at a noteworthy CAGR of 9.8% through 2034, bottles are projected to account for a significant market share of 43.6%. Adoption of glass bottles is increasing in the pharmaceutical industry because they are less harmful and more eco-friendly compared to plastic bottles. The design of bottles serves a purpose in the storage and packaging of a wide range of medicines and chemicals.
Why are Sales of Glass Intended for Primary Product Packaging Increasing?
“Primary Packaging Playing Crucial Role in Maintaining Product Safety and Efficacy”
| Attribute | Primary Products |
|---|---|
| Market Value (2024E) | US$ 7.2 Billion |
| Growth Rate (2024 to 2034) | 9.1% CAGR |
| Projected Value (2034F) | US$ 17 Billion |
Demand for primary packaging products is on the rise in the pharmaceutical industry as they play an important role in ensuring product safety, efficacy, and integrity. Primary packaging, encompassing vials, bottles, syringes, and more, serves as the first layer of defense against external contaminants. Glass is chemically inert and impermeable and thus serves as the perfect barrier for preserving the potency and stability of pharmaceutical formulations, particularly those sensitive to light, moisture, or oxygen.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the pharmaceutical glass packaging industry are Schott AG, Owens-Illinois, Inc., Beatson Clark, Nipro Corporation, West Pharmaceutical Services, Inc., Piramal Glass, DWK Life Sciences GmbH, Corning Incorporated, Stolzle Oberglas GmbH, Amposan S.A., and West Pharmaceutical Services, Inc.
Companies are focusing on innovation to better serve the needs of pharmaceutical manufacturers throughout the world. Innovative biotech pharmaceuticals are coming onto the market in greater numbers. These drugs require injection and must be given in vials and prefilled syringes in appropriate proportions.
- In February 2024, SCHOTT, which produces specialty glass and glass ceramics, expanded its operations in Müllheim to meet the growing need for premium polymer pharmaceutical packaging.
- In October 2023, to satisfy the demands of the pharmaceutical business, SCHOTT developed Type I FIOLAX Pro borosilicate glass tubing for the next generation.
- In September 2023, Corning Inc. introduced Corning Viridian Vials, thus expanding its pharmaceutical glass packaging range.
- In June 2023, Corning Incorporated and SGD Pharma established a joint venture to construct a new glass tubing factory in India to increase their pharmaceutical production capacity.
- In May 2021, Nipro PharmaPackaging, a packaging company based in Japan, acquired Piramida, a Croatian glass pharmaceutical packaging producer.
Segmentation of Pharmaceutical Glass Packaging Market Research
-
By Product Type :
- Bottles
- Syringes
- Ampoules & Vials
- Cartridges
-
By Material :
- Primary
- Secondary
- Tertiary
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
- FAQs -
What is the size of the pharmaceutical glass packaging market?
The global pharmaceutical glass packaging market is estimated at US$ 18.4 billion in 2024.
What is the projected valuation of the pharmaceutical glass packaging market for 2034?
The market for pharmaceutical glass packaging is projected to reach US$ 43.6 billion by 2034-end.
How fast is the market for pharmaceutical glass packaging projected to expand?
The market is projected to expand at a CAGR of 9% from 2024 to 2034.
At what pace is the market projected to grow in Japan?
The market in Japan is projected to expand at a CAGR of 9.7% through 2034.
What share of the global market is North America projected to hold by 2034?
North America is forecasted to account for 15.2% share of the global market by 2034.
What are the top pharmaceutical glass packaging companies?
Key market players are Schott AG, Owens-Illinois, Inc., Nipro Corporation, and West Pharmaceutical Services, Inc.
Pharmaceutical Glass Packaging Market
*Mail attachment includes 132 figures & 25 tables